Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

Galapagos Enters New RA Alliance With Janssen

Oct. 31, 2007

By Peter O'Donnell

Europe Still Undecided In Prolonged GM Debate

Oct. 31, 2007

By Peter O'Donnell

Europe Still Undecided In Prolonged GM Debate

Oct. 31, 2007

By Peter O'Donnell

Galapagos Enters New RA Alliance With Janssen

Oct. 31, 2007

By Peter O'Donnell

OncoMethylome Raises $14M; Galapagos Wins $7M In Grants

Oct. 24, 2007

By Peter O'Donnell

OncoMethylome Raises $14M; Galapagos Wins $7M In Grants

Oct. 24, 2007

By Peter O'Donnell

EuropaBio Takes Its Message To The Top

Oct. 17, 2007

By Peter O'Donnell

EuropaBio Takes Its Message To The Top

Oct. 17, 2007

By Peter O'Donnell

EU Industry Puts Brave Face On Clinical Trials Dead End

Oct. 10, 2007

By Peter O'Donnell

EU Industry Puts Brave Face On Clinical Trials Dead End

Oct. 10, 2007

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...